EP.TH.37Radioembolization with yttrium-90 microspheres for management of breast liver metastases: a systematic review and pooled analysis
نویسندگان
چکیده
Abstract Aims Radioembolization with yttrium-90 microspheres is an emerging option for management of liver metastases breast cancer when other systemic therapies have failed. The aims this systematic review were to assess the effect radioembolization on i) tumour response and ii) patient survival post -radioembolization. Methods was performed using Preferred Reporting Items Systematic Reviews Meta-Analyses (PRISMA). A literature search PubMed EMBASE databases from January 2007 December 2019. initial yielded 265 reports which potentially suitable inclusion in review. Studies published English reporting at least one outcome interest considered be inclusion. Conference abstracts; case reports, animal studies not excluded Results final number met criteria 12 (n = 452 patients). There no randomized controlled trials identified. age patients included ranged 52 61 years. duration follow-up 6 15.7 months. total confined 236 (52.2%). Cumulative analysis revealed that conferred control rate 81% patients. Overall post-radioembolization 3.6 20.9 months estimated mean 11.3 Conclusion ytrrium-90 appears confer growth most patients, however its need elucidated further.
منابع مشابه
Radioembolization with yttrium-90 microspheres for pancreatic cancer liver metastases: results from a pilot study.
BACKGROUND Patients with liver metastases from pancreatic adenocarcinomas have a dismal prognosis. Surgical resection remains the only curative option but is appropriate for only a minority of patients as a treatment option. This is the first study to examine the safety and efficacy of radioembolization with yttirum-90 microspheres for these patients. PATIENTS AND METHODS All patients with hi...
متن کاملRadioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.
PURPOSE We aimed to evaluate the effectiveness and safety of radioembolization with yttrium-90 (90Y) microspheres in cases with unresectable neuroendocrine tumor liver metastases (NETLMs). METHODS Thirty patients (mean age, 55 years) underwent resin-based 90Y radioembolization for unresectable NETLM at a single institution between April 2008 and June 2013. Post-treatment tumor response was as...
متن کاملRadioembolization of liver tumors with yttrium-90 microspheres.
Radioembolization (RE), also termed selective internal radiation therapy (SIRT), has been gradually introduced to the clinical arsenal of cytoreductive modalities in recent years. There is growing evidence for efficiency in liver tumors of various entities, with the most prominent ones being hepatocellular carcinoma, colorectal cancer, and neuroendocrine tumors. Hepatic metastases of numerous o...
متن کاملYttrium-90 microspheres: a review of its emerging clinical indications.
BACKGROUND Many patients with liver malignancies are not candidates for resection, and systemic therapies are often not effective. Radioembolization (RE) is an alternative treatment for this group of patients. The safety and efficacy of RE with yttrium 90 (Y90) in patients with hepatocellular carcinoma (HCC) or metastatic colon cancer to the liver have been proven in several studies. However, f...
متن کاملYttrium-90 Radioembolization for Pancreatic Neuroendocrine Liver Metastases
Background: Management options for pancreatic neuroendocrine tumors (pNETs) metastatic to the liver include surgical, ablative, cytotoxic, and radioisotope approaches. One potential local treatment option includes selective internal radiotherapy utilizing yttrium-90 ( 90 Y) microspheres. 90 Y has also been used in the treatment of hepatocellular carcinoma and tumors metastatic to the liver. It ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Surgery
سال: 2021
ISSN: ['1365-2168', '0007-1323']
DOI: https://doi.org/10.1093/bjs/znab309.006